AGN,CORRECTED-Allergan rejects Valeant Pharma's takeover bidBRIEF-Valeant to pursue Allergan despite rejectionCANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)        CANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       * Valeant spokeswoman says disappointed by Allergan rejection, committed to pursuing transaction    (Reporting by Caroline Humer)CANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)         BRIEF-Valeant to pursue Allergan despite rejectionCANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)        CANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       * Valeant spokeswoman says disappointed by Allergan rejection, committed to pursuing transaction    (Reporting by Caroline Humer)CANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)        May 12 U.S. medical firm Allergan Inc  rejected the unsolicited takeover offer from Valeant Pharmaceuticals International Inc , saying it substantially undervalued the company.BRIEF-Valeant to pursue Allergan despite rejectionCANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)        CANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       * Valeant spokeswoman says disappointed by Allergan rejection, committed to pursuing transaction    (Reporting by Caroline Humer)CANADA STOCKS-Natural resource prices, shares drive TSX higherAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)       Ackman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      * TSX rises 93.72 points, or 0.64 percent, to 14,627.78     * All of 10 main index sectors advance     * Valeant slips after Allergan rejects bid      By John Tilak     TORONTO, May 12 Canada's main stock index climbed on Monday as a rally in the prices of commodities such as gold, copper and oil helped drive up shares of natural resource companies.     Commodity prices benefited from worries about the situation in Ukraine and a weaker U.S. dollar.      Ukrainian leader Oleksander TuAckman asks for Allergan's stockholder listUPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)      UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     BOSTON, May 12 William Ackman plans to reach out to other Allergan shareholders after the Botox-maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 1-Ackman asks for Allergan's stockholder listAckman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)     Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    BOSTON, May 12 William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.Ackman asks for Allergan's stockholder listUPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)    UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   BOSTON William Ackman plans to communicate with other Allergan shareholders after the Botox maker on Monday rebuffed a bid to be bought by the billionaire investor and Valeant Pharmaceuticals.UPDATE 4-Allergan rejects Valeant Pharma's 'cut and slash' takeoverAllergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)   Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  * Allergan expects EPS growth of 20-25 percent   (Adds Ackman's fund asking for Allergan shareholder list, paragraphs 10-11)Allergan rejects Valeant Pharma's 'cut and slash' takeoverDeals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)  Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire) U.S. drugmaker Allergan Inc  on Monday rejected Valeant Pharmaceuticals International Inc's  $47 billion takeover offer, saying its proposed cost cuts were too steep.Deals of the day- Mergers and acquisitions (Adds Mitsubishi Chemical, Abertis, Gerdau; updates Hillshire Brands, Allergan, Shire)         
GOOGL,Plaintiff in tech hiring suit asks judge to reject settlement May 12 One of the plaintiffs in a lawsuit that accuses tech firms including Apple Inc and Google Inc  of conspiring to hold down salaries has asked the court to reject a $324 million settlement negotiated by his own lawyers. 
GOOG,Plaintiff in tech hiring suit asks judge to reject settlement May 12 One of the plaintiffs in a lawsuit that accuses tech firms including Apple Inc and Google Inc  of conspiring to hold down salaries has asked the court to reject a $324 million settlement negotiated by his own lawyers. 
AIG,AIG narrows CEO search to two internal candidates - WSJ May 12 American International Group Inc's  search for its next chief executive has narrowed down to two internal candidates, the Wall Street Journal reported, citing people familiar with the matter. 
AAPL,Plaintiff in tech hiring suit asks judge to reject settlementPlaintiff in tech hiring suit asks judge to reject settlementApple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website.  Apple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website. One of the plaintiffs in a lawsuit that accuses tech firms including Apple Inc and Google Inc of conspiring to hold down salaries has asked the court to reject a $324 million settlement negotiated by his own lawyers.Apple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website.   Plaintiff in tech hiring suit asks judge to reject settlementApple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website.  Apple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website. One of the plaintiffs in a lawsuit that accuses tech firms including Apple Inc and Google Inc of conspiring to hold down salaries has asked the court to reject a $324 million settlement negotiated by his own lawyers.Apple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website.  May 12 One of the plaintiffs in a lawsuit that accuses tech firms including Apple Inc and Google Inc  of conspiring to hold down salaries has asked the court to reject a $324 million settlement negotiated by his own lawyers.Plaintiff in tech hiring suit asks judge to reject settlementApple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website.  Apple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website. One of the plaintiffs in a lawsuit that accuses tech firms including Apple Inc and Google Inc of conspiring to hold down salaries has asked the court to reject a $324 million settlement negotiated by his own lawyers.Apple tries to lift online sales by cutting refund times in half SAN FRANCISCO, May 12 Apple Inc has cut in half the time it takes to give refunds to online store customers who want to return their iPhones and other gadgets, a small but crucial step to try to get more people to buy direct from its website.   
T,UPDATE 2-Gogo revenue jumps as more users access in-flight InternetAT&T; to strike deal with DirecTV in as soon as two weeks - WSJBRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.    BRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   May 12 AT&T; Inc is expected to strike a deal with DirecTV in as early as two weeks, the Wall Street Journal reported on Monday, citing sources.BRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.     AT&T; to strike deal with DirecTV in as soon as two weeks - WSJBRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.    BRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   May 12 AT&T; Inc is expected to strike a deal with DirecTV in as early as two weeks, the Wall Street Journal reported on Monday, citing sources.BRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.    * Shares rise as much as 10.6 pct   (Adds details, updates shares)AT&T; to strike deal with DirecTV in as soon as two weeks - WSJBRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.    BRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   May 12 AT&T; Inc is expected to strike a deal with DirecTV in as early as two weeks, the Wall Street Journal reported on Monday, citing sources.BRIEF-AT&T; in advanced talks to acquire DirecTVUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.   US STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  * AT&T;, DirecTV working toward deal announcement within next two weeks-sourceUS STOCKS-Dow, S&P; 500 end at record highs; DirecTV up lateAT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.  AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday. * Dow up 0.7 pct; S&P; 500 up 1 pct; Nasdaq up 1.8 pct   (Updates close with DirecTV shares up after the bell, adds 21st Century Fox and latest volume)AT&T; in advanced talks to buy DirecTV for about $50 billion: source AT&T; Inc is in advanced talks to buy satellite TV provider DirecTV for about $100 per share, or roughly $50 billion, a person familiar with the matter said on Monday.     
BIIB,Biogen, Sobi pledge hemophilia drug donation in developing world May 12 Biogen Idec Inc and partner Swedish Orphan Biovitrum AB on Monday said they will donate hemophilia drugs for use in developing nations in quantities large enough to treat tens of thousands of patients over the next decade. 
DAL,TIMELINE-Delta Air Lines' and Carlyle's efforts to ease U.S. ethanol rules NEW YORK, May 12 In 2013, Delta Air Lines and The Carlyle Group joined the refining industry in lobbying to lower federal mandates on how much ethanol and other biofuels have to be blended into U.S. fuel supplies. 
GM,GM ranked worst automaker by U.S. suppliers -surveyGM ranked worst automaker by U.S. suppliers: surveyGM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.   GM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  DETROIT General Motors Co , already locked in a public relations crisis because of a deadly ignition defect that has triggered the recall of 2.6 million vehicles, has a new perception problem on its hands.GM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.    GM ranked worst automaker by U.S. suppliers: surveyGM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.   GM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  DETROIT General Motors Co , already locked in a public relations crisis because of a deadly ignition defect that has triggered the recall of 2.6 million vehicles, has a new perception problem on its hands.GM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.   DETROIT, May 12 General Motors Co, already locked in a public relations crisis because of a deadly ignition defect that has triggered the recall of 2.6 million vehicles, has a new perception problem on its hands.GM ranked worst automaker by U.S. suppliers: surveyGM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.   GM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  DETROIT General Motors Co , already locked in a public relations crisis because of a deadly ignition defect that has triggered the recall of 2.6 million vehicles, has a new perception problem on its hands.GM reassigns executive who dealt with ignition switch probeGM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.  GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday. DETROIT, May 12 General Motors Co has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.GM reassigns executive who dealt with ignition switch probe DETROIT General Motors Co  has reassigned an executive who dealt with U.S. safety regulators probing defective ignition switches linked to at least 13 deaths, as part of a restructuring meant to improve vehicle safety, the automaker said on Monday.    
GS,Mercuria hires ex-Goldman executive to run tradingUPDATE 1-Mercuria hires ex-Goldman executive to run tradingUPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen  UPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen * Move comes as Mercuria closing purchase of JPM's businessUPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen   UPDATE 1-Mercuria hires ex-Goldman executive to run tradingUPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen  UPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen * Move comes as Mercuria closing purchase of JPM's businessUPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen  LONDON, May 12 Fast growing Swiss trading house Mercuria has hired a former top executive from Goldman Sachs  to run its global commodities trading, as it expands further into the territory abandoned by many top Wall Street lenders under tighter regulatory scrutiny.UPDATE 1-Mercuria hires ex-Goldman executive to run tradingUPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen  UPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen * Move comes as Mercuria closing purchase of JPM's businessUPDATE 1-Glencore, Goldman warehouses have longest aluminium queues-LME report * Longest queue over 2 yrs in aluminium at Pacorini in Vlissingen   
IBM,IBM facing "rocky time", but poised for change, CEO says - NYTUS STOCKS-Futures rise, S&P; 500 near recordThree Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger.  Three Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger. NEW YORK, May 12 U.S. stock index futures rose on Monday, putting the S&P; 500 within striking distance of record levels, though geopolitical concerns in the Ukraine could cap gains.Three Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger.   US STOCKS-Futures rise, S&P; 500 near recordThree Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger.  Three Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger. NEW YORK, May 12 U.S. stock index futures rose on Monday, putting the S&P; 500 within striking distance of record levels, though geopolitical concerns in the Ukraine could cap gains.Three Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger.  May 11 IBM Corp is facing a "rocky time," Chief Executive Virginia Rometty told the New York Times, but said she and the company now have a clear vision on how to pursue another generation of growth.US STOCKS-Futures rise, S&P; 500 near recordThree Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger.  Three Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger. NEW YORK, May 12 U.S. stock index futures rose on Monday, putting the S&P; 500 within striking distance of record levels, though geopolitical concerns in the Ukraine could cap gains.Three Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger.   
JPM,Gains in mining stocks nudge UK's FTSE higherGains in mining stocks nudge UK's FTSE higher LONDON, May 12 A rise in heavyweight mining stocks lifted Britain's top equity index on Monday back towards its highest level since early 2000.  Gains in mining stocks nudge UK's FTSE higher LONDON, May 12 A rise in heavyweight mining stocks lifted Britain's top equity index on Monday back towards its highest level since early 2000. LONDON, May 12 A rise in heavyweight mining stocks lifted Britain's top equity index on Monday, pushing the UK stock market back towards its highest level since early 2000.Gains in mining stocks nudge UK's FTSE higher LONDON, May 12 A rise in heavyweight mining stocks lifted Britain's top equity index on Monday back towards its highest level since early 2000.  
MCK,McKesson fourth-quarter profit tops forecasts May 12 U.S. drug wholesaler McKesson Corp  on Monday said profit rose in the latest quarter, exceeding analyst expectations, thanks to strength in its distribution and technology solutions units. 
MS,ON THE MOVE-Raymond James hires adviser from Morgan Stanley May 12 Raymond James Financial Inc's  broker-dealer unit said it hired veteran adviser Stephen Besse from Morgan Stanley for its Walnut Creek, California office. 
ORCL,Three Lawson Software founders settle SEC insider trading charges May 12 Three Lawson Software Inc founders agreed to pay about $5.8 million to settle U.S. insider trading charges that they took advantage of incorrect media and analyst reports to trade stock ahead of the company's 2011 merger. 
PFE,RPT-UK labs play shrinking role in AstraZeneca drug portfolioPfizer R&D; head presses case for AstraZeneca dealPfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.     Pfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    LONDON, May 12 Pfizer's research head pressed the case for combining with AstraZeneca on Monday in the latest stage of a campaign by the U.S. drugmaker to counter critics of its proposed $106 billion deal.Pfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.      Pfizer R&D; head presses case for AstraZeneca dealPfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.     Pfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    LONDON, May 12 Pfizer's research head pressed the case for combining with AstraZeneca on Monday in the latest stage of a campaign by the U.S. drugmaker to counter critics of its proposed $106 billion deal.Pfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.     * Global drug companies agnostic in sourcing best sciencePfizer R&D; head presses case for AstraZeneca dealPfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.     Pfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    LONDON, May 12 Pfizer's research head pressed the case for combining with AstraZeneca on Monday in the latest stage of a campaign by the U.S. drugmaker to counter critics of its proposed $106 billion deal.Pfizer says its commitments to UK legally bindingRPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.    RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.RPT-Pfizer says its commitments to UK legally bindingUPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.   UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  LONDON, May 12 U.S. drugmaker Pfizer  said on Monday its commitments to  preserving British science jobs if it wins a $106 billion battle to take over AstraZeneca  were legally binding.UPDATE 2-Pfizer defends "powerhouse" Astra deal as CEO braces for grillingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.  Arthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials. * U.S. firm says commitments to Britain are legally bindingArthritis and lupus data a shot in arm for AstraZeneca LONDON, May 12 AstraZeneca, fighting a $106 billion bid approach from Pfizer, received a fillip on Monday as two experimental drugs for rheumatoid arthritis and lupus met their goals in mid-stage clinical trials.      
FOXA,BSkyB confirms talks with Fox over assets in Germany, Italy21st Century Fox notes previous talks on Sky assets, but no agreement reached21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."   21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  LONDON, May 12 Rupert Murdoch's 21st Century Fox  said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."    21st Century Fox notes previous talks on Sky assets, but no agreement reached21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."   21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  LONDON, May 12 Rupert Murdoch's 21st Century Fox  said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."   FRANKFURT, May 12 British Sky Broadcasting Group Plc said on Monday it was in early talks with Rupert Murdoch's 21st Century Fox over the possible acquisition of its pay-TV assets in Germany and Italy,     Sky Deutschland and Sky Italia, confirming weekend reports.21st Century Fox notes previous talks on Sky assets, but no agreement reached21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."   21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  LONDON, May 12 Rupert Murdoch's 21st Century Fox  said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."    
FOX,BSkyB confirms talks with Fox over assets in Germany, Italy21st Century Fox notes previous talks on Sky assets, but no agreement reached21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."   21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  LONDON, May 12 Rupert Murdoch's 21st Century Fox  said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."    21st Century Fox notes previous talks on Sky assets, but no agreement reached21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."   21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  LONDON, May 12 Rupert Murdoch's 21st Century Fox  said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."   FRANKFURT, May 12 British Sky Broadcasting Group Plc said on Monday it was in early talks with Rupert Murdoch's 21st Century Fox over the possible acquisition of its pay-TV assets in Germany and Italy,     Sky Deutschland and Sky Italia, confirming weekend reports.21st Century Fox notes previous talks on Sky assets, but no agreement reached21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."   21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  LONDON, May 12 Rupert Murdoch's 21st Century Fox  said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.21st Century Fox notes previous talks on Sky assets, but no agreement reachedFox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."  Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol." LONDON Rupert Murdoch's 21st Century Fox said on Monday that it had held numerous talks about combining the Sky-branded European satellite platforms in Britain, Germany and Italy, but it noted that no agreement had ever been reached.Fox cuts 'American Idol' hours, unveils Batman show May 12 Twenty-First Century Fox Inc's  schedule for the upcoming television season will feature a high-profile show on Batman called "Gotham," while the company will reduce the air time for the struggling singing contest program "American Idol."    
UNP,Union Pacific train derails in Colorado, spills 5,300 gallons of oilCORRECTED-(OFFICIAL)-UPDATE 1-Union Pacific line in Colorado operating after derailmentUnion Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service.  Union Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service. (Company corrects to say rail line back in service Sunday, not Saturday in 5th paragraph)Union Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service.   CORRECTED-(OFFICIAL)-UPDATE 1-Union Pacific line in Colorado operating after derailmentUnion Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service.  Union Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service. (Company corrects to say rail line back in service Sunday, not Saturday in 5th paragraph)Union Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service.  May 12 Union Pacific said Monday a train derailed early Friday in northern Colorado, spilling 5,300 gallons of oil.   (Reporting by Scott DiSavino, Editing by Franklin Paul)CORRECTED-(OFFICIAL)-UPDATE 1-Union Pacific line in Colorado operating after derailmentUnion Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service.  Union Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service. (Company corrects to say rail line back in service Sunday, not Saturday in 5th paragraph)Union Pacific line in Colorado operating after derailment U.S. railroad company Union Pacific Corp said on Monday that a rail line on which a train derailed near the town of LaSalle in northern Colorado was back in service.   
